TECX NASDAQ
Credit Risk of going bust: lower than 70% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 99.9%), Tectonic Therapeutic, Inc. would be worth roughly what it owes.
Total debt $4.4M against a stock market value of $390.0M.
Distance to default 7.55 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 72.0%; Altman Z'' 17.79. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Watertown, MA 02472
US
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McNamara Peter | S-Sale | 536 | $23.04 | 2026-09-30 |
| Ruddy Marcella K. | F-InKind | 525 | $23.67 | 2026-09-25 |
| REICIN ALISE | F-InKind | 1,545 | $23.67 | 2026-09-25 |
| Schwabish Marc | F-InKind | 411 | $23.67 | 2026-09-25 |
| Lochner Daniel | F-InKind | 520 | $23.67 | 2026-09-25 |